The advertisement promotes NUBEQA, a medication approved for men with prostate cancer that has metastasized. It emphasizes the drug's new approval status and includes important safety information.
Creative Information
| CID: | c0401156-48d1-4e11-a529-1a46ba3b63f4 |
| CRID: | 82_1075-793595 |
| Domain: | nubeqa-us.com |
| Seat: | PP |
| Size: | 300x600 |
| Bid: | $0.57 |
| Timestamp: | 11/1/2025, 4:23:56 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/1/2025, 5:02:16 AM | 5.04s | |
| adomain_analysis | success | 11/1/2025, 5:56:19 AM | 2.58s | |
| adomain_capture | success | 11/1/2025, 5:56:17 AM | 0.09s | |
| ad_render | success | 11/1/2025, 5:02:10 AM | 27.24s | |
| brand_mapping | success | 11/1/2025, 4:23:56 AM | 0.07s | |
Analysis Results
Ad Format: banner
Brands: Nubeqa
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1016.78 KB | ||||||||||||||||||||||
| Render Time: | 10.94 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1023.67 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Landing Page
Creatives
